
Merida Biosciences
Developer of targeted immunotherapies designed for the treatment of autoimmune and allergic diseases. The company's platform focuses on the selective elimination of disease-causing antibody-producing ...
Valuation
$228M
Latest known
Share Price
N/A
Total Raised
$154M
Last Round
N/A